Intersect ENT (XENT) Tops Q4 EPS by 5c

Intersect ENT (NASDAQ: XENT) reported Q4 EPS of ($0.20), $0.05 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $18.8 million versus the consensus estimate of $18.36 million.

For earnings history and earnings-related data on Intersect ENT (XENT) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Baidu slips as Q2 results miss estimates despite growth in AI cloud business
• DeFi Technologies (DEFT) PT Lowered to $1 at Benchmark Following Q2 Miss